IndraLab

Statements


1 | 2

reach
"Recent reports indicate that curcumin inhibits mammalian CTSB and CTSH with IC 50 in the nanomolar range under in vitro conditions."

reach
"First, mTOR suppression is required for Curcumin induced lysosomal activation, based on two important findings : (i) Curcumin treatment inhibits the Akt-mTOR pathway, which is consistent with the previous reports; [XREF_BIBR, XREF_BIBR] (ii) Curcumin fails to block mTOR activity and increase lysosomal acidification and Cathepsin B activity in Tsc2 -/- MEFs."